Pre-clinical Implantation study in collaboration with RISE, SÖS and CCMIJU
- Biomedical Bonding
- Jul 16
- 1 min read
We are thrilled to announce the launch of our latest pre-clinical implantation study, conducted in collaboration with Research Institutes of Sweden (RISE), Södersjukhuset (SÖS), and Centro de Cirugía de Mínima Invasión Jesús Usón (CCMIJU). This 13-week study marks an important step in evaluating the biocompatibility and safety performance of AdhFix - Biomedical Bonding AB’s innovative fracture fixation technology, relying on our patented Bonevolent™ platform.
AdhFix combines metal screws with an in-situ customisable, light-curable composite that can conform to complex and irregular bone geometries. This unique capability makes it especially suitable for challenging and comminuted fractures where traditional fixation methods often fall short. Furthermore, its carefully tailored chemical composition eliminates soft tissue adhesions, promising a reduction in post-surgical complications.
In partnership with Joakim Håkansson (RISE), Marianne Arner (SÖS), and Elena Abellán Rubio (CCMIJU), AdhFix has been implanted into Sprague-Dawley rodents for in-vivo evaluation. The study, conducted under Good Laboratory Practice (GLP) conditions, will assess AdhFix’s long-term safety, biocompatibility, and integration with surrounding tissue through detailed histopathological analysis. This project is funded by Eurostars through the MedTech4Health initiative.
We extend our sincere gratitude to Elena Abellán Rubio, Head of the Microsurgery Unit, for her expert coordination and supervision of the study, as well as to Dr. Francisco Javier Vela González and Joakim Håkansson for performing the surgeries. A special thank you goes to the skilled surgical team at CCMIJU for their invaluable support throughout the process.
Stay tuned for updates as we move closer to a new frontier in fracture fixation and surgical innovation!
Comments